PUBLICACIÓN

Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Arlander, E., Ekström, G., Alm, C., Carrillo, J.A., Bielenstein, M., Böttiger, Y., Bertilsson, L., Gustafsson, L.L.

1998 Clinical Pharmacology and Therapeutics


CITAS

74

DOI

10.1016/s0009-9236(98)90131-x

EID

2-s2.0-0031775019

ISSN

0009-9236

BIBTEX

@article{Carrillo Norte1998,title = {Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors},journal = {Clinical Pharmacology and Therapeutics},year = {1998},volume = {64},number = {5},pages = {484-491},author = {Arlander, E. and Ekström, G. and Alm, C. and Carrillo, J.A. and Bielenstein, M. and Böttiger, Y. and Bertilsson, L. and Gustafsson, L.L.}}


AUTORES DE LA UEX